Rigel Pharmaceuticals Inc (RIGL): Weighted Average Diluted Shares

Annual figures by period end, from SEC filings.

Stock splits: 1-for-10, first reflected in a filing dated 2024-08-06. Figures are as filed: per-share figures and share counts last reported before a split are on the old share basis, so changes and growth rates across a split are not shown. Splits are read from the filings' own restatements, so a share conversion in a merger or reorganization shows up the same way.

18.84M
Year ended 2025-12-31
+3.4%
3-year compound annual growth
170.49M2009-12-31: 40.88M2010-12-31: 52.57M2011-12-31: 63.33M2012-12-31: 74.97M2013-12-31: 87.29M2014-12-31: 87.66M2019-12-31: 167.40M2020-12-31: 168.75M2021-12-31: 170.49M2022-12-31: 17.05M2023-12-31: 17.40M2024-12-31: 17.69M2025-12-31: 18.84M18.84M
2009-12-31 Weighted Average Diluted Shares (shares) 2025-12-31

Paler bars were last filed before a stock split, on the old share basis.

Period endedWeighted Average Diluted SharesChange YoYSource filing
2025-12-3118.84M+6.5%2026-03-03, From 2025-01-01
2024-12-3117.69M+1.6%2026-03-03, From 2024-01-01
2023-12-3117.40M+2.1%2026-03-03, From 2023-01-01
2022-12-3117.05Mn/c2025-03-04, From 2022-01-01
2021-12-31170.49M+1.0%2024-03-05, From 2021-01-01
2020-12-31168.75M+0.8%2023-03-07, From 2020-01-01
2019-12-31167.40Mn/c2022-03-01, From 2019-01-01
No annual figure between 2014-12-31 and 2019-12-31.
2014-12-3187.66M+0.4%2015-03-03, From 2014-01-01
2013-12-3187.29M+16.4%2015-03-03, From 2013-01-01
2012-12-3174.97M+18.4%2015-03-03, From 2012-01-01
2011-12-3163.33M+20.5%2014-03-04, From 2011-01-01
2010-12-3152.57M+28.6%2013-03-05, From 2010-01-01
2009-12-3140.88Mn/a2012-03-06, From 2009-01-01